Russia has approved R-Pharm's Coronavir treatment for outpatients with mild to moderate Covid-19 infections and the antiviral drug could be rolled out to pharmacies in the country as soon as next week. Coronavir's approval as a prescription drug follows the green light for another Russian Covid-19 drug, Avifavir, in May.
